Deciphering the mechanism of action of antitubercular compounds with metabolomics
Tuberculosis (TB), one of the oldest and deadliest bacterial diseases, continues to cause serious global economic, health, and social problems. Current TB treatments are lengthy, expensive, and routinely ineffective against emerging drug resistant strains. Thus, there is an urgent need for the ident...
Main Authors: | Isin T. Sakallioglu, Raúl G. Barletta, Patrick H. Dussault, Robert Powers |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S200103702100324X |
Similar Items
-
Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds
by: Guilherme Felipe dos Santos Fernandes, et al.
Published: (2017-06-01) -
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug
by: Giorgia Mori, et al.
Published: (2020-02-01) -
Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets
by: Davide M. Ferraris, et al.
Published: (2018-02-01) -
Antitubercular compounds
by: TSAO, Shung Ling
Published: (1949) -
Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3
by: Giulia Degiacomi, et al.
Published: (2020-01-01)